Google
Trusted Resources: News & Events
Latest announcements and gatherings
Pfizer’s Kevin Williams to Pen Health Column on Sickle Cell Disease for the Black Press
Dr. Kevin Williams, the Chief Medical Officer, for Pfizer’s rare disease unit, plans to help educate the masses about sickle cell disease (SCD) in a new column for the National Newspaper Publishers Association (NNPA).
Earlier this year, Pfizer Inc. and the NNPA, a trade association of more than 200 African American-owned media companies in the United States, announced a collaboration to raise awareness of SCD, a lifelong and debilitating genetic disorder that affects red blood cells. According to the Centers for Disease Control and Prevention, SCD occurs in 1 out of every 365 Black or African-American births.
Williams said that the column is a part of the collaboration between Pfizer and the NNPA to raise awareness about SCD and the importance of clinical trial participation in the process for developing new medications.
“We’ll be covering a number of topics including tips for living with sickle cell disease, common myths about the disease, and how to support a friend or family member with the disease”, said Williams.
+myBinderRelated Content
-
Monica SummersMonica Summers has been employed with Pi...
-
Miai & Ama Talk About Sickle Cell Diseasehttps://www.youtube.com/watch?v=7bUFGux-...
-
Southwest Louisiana Sickle Cell AnemiaSouthwest Louisiana Sickle Cell Anemia, ...
-
@sicklecellnewsWe are the world's first dedicated sickl...
-
Pat Corley, RNPat Corley is a retired nurse coordinato...
-
Global Alliance of Sickle Cell Disease OrganizationsGlobal Alliance of Sickle Cell Disease O...
-
Rare Disease Day Symposium at the Quinnipiac Frank H. Netter MD School of MedicineSince 2015, the Frank H. Netter MD Schoo...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.